Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154)
- 1 January 1975
- journal article
- research article
- Published by Springer Nature in Archiv für Gynäkologie
- Vol. 220 (1) , 83-87
- https://doi.org/10.1007/bf00673151
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- TREATMENT OF THE PREMENSTRUAL SYNDROME WITH BROMOCRYPTINEActa Endocrinologica, 1975
- Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptine (CB 154) clinical response and pattern of pituitary and steroid hormones before and during therapyArchiv für Gynäkologie, 1975
- Clinical and Hormonal Response To Bromocriptin (CB-154) in the Galactorrhea SyndromesJournal of Clinical Endocrinology & Metabolism, 1974
- A NEW APPROACH TO THE INHIBITION OF PUERPERAL LACTATIONBJOG: An International Journal of Obstetrics and Gynaecology, 1973
- THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine)Journal of Clinical Endocrinology & Metabolism, 1972
- Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptineBMJ, 1972
- [Inhibition of puerperal lactation with ergot alkaloids].1972
- A Radioimmunoassay for Human ProlactinProceedings of the National Academy of Sciences, 1971
- Treatment of Non-puerperal Galactorrhoea with an Ergot AlkaloidBMJ, 1971